عنوان ترانسليتريتد: Tumores del sistema nervioso central. Clasificación de la Organización Mundial de la Salud 2021. Hacia un cambio de paradigma.

المؤلفون: Del Río RJ; Department of Pulmonology, Hospital de Pediatría S.A.M.I.C. Prof. Dr. Juan P. Garrahan, City of Buenos Aires, Argentina., Cicutti SE; Department of Pulmonology, Hospital de Pediatría S.A.M.I.C. Prof. Dr. Juan P. Garrahan, City of Buenos Aires, Argentina., González Ramos JD; Department of Pulmonology, Hospital de Pediatría S.A.M.I.C. Prof. Dr. Juan P. Garrahan, City of Buenos Aires, Argentina.

المصدر: Archivos argentinos de pediatria [Arch Argent Pediatr] 2024 Aug 01; Vol. 122 (4), pp. e202310219. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sociedad Argentina de Pediatría Country of Publication: Argentina NLM ID: 0372460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1668-3501 (Electronic) Linking ISSN: 03250075 NLM ISO Abbreviation: Arch Argent Pediatr Subsets: MEDLINE

مواضيع طبية MeSH: World Health Organization* , Central Nervous System Neoplasms*/classification , Central Nervous System Neoplasms*/diagnosis, Humans ; Child

المؤلفون: Mousavi SE; Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. mousavi.e@tbzmed.ac.ir.; Department of Community Medicine, Social Determinants of Health Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. mousavi.e@tbzmed.ac.ir., Seyedmirzaei H; Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Interdisciplinary Neuroscience Research Program (INRP), Tehran University of Medical Sciences, Tehran, Iran., Shahrokhi Nejad S; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Nejadghaderi SA; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. a.nejadghaderi@kmu.ac.ir.; Systematic Review and Meta‑analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. a.nejadghaderi@kmu.ac.ir.

المصدر: Scientific reports [Sci Rep] 2024 Sep 20; Vol. 14 (1), pp. 21936. Date of Electronic Publication: 2024 Sep 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Central Nervous System Neoplasms*/epidemiology , Central Nervous System Neoplasms*/mortality , Brain Neoplasms*/epidemiology , Brain Neoplasms*/mortality, Humans ; Asia/epidemiology ; Male ; Female ; Incidence ; Socioeconomic Factors ; Middle Aged ; Adult ; Prevalence ; Aged

المؤلفون: Hickman RA; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.; Foundation Medicine, Inc., 150 Second Street, Cambridge, MA, 02141, USA., Miller AM; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Department of Neurology, Perlmutter Cancer Center, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, 10016, USA., Holle BM; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA., Jee J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Liu SY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Ross D; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Yu H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Ombres C; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Gewirtz AN; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Reiner AS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Nandakumar S; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA., Price A; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Kaley TJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Graham MS; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Vanderbilt C; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Rana S; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Hill K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Chabot K; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA., Campos C; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA., Nafa K; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Karajannis M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Li B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Berger M; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Ladanyi M; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Pentsova E; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Boire A; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA.; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Brannon AR; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Bale T; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA., Mellinghoff IK; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA. mellingi@mskcc.org.; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA. mellingi@mskcc.org., Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA. arcilam@mskcc.org.

المصدر: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Sep 17; Vol. 12 (1), pp. 151. Date of Electronic Publication: 2024 Sep 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101610673 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-5960 (Electronic) Linking ISSN: 20515960 NLM ISO Abbreviation: Acta Neuropathol Commun Subsets: MEDLINE

مواضيع طبية MeSH: Circulating Tumor DNA*/cerebrospinal fluid , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Central Nervous System Neoplasms*/cerebrospinal fluid , Central Nervous System Neoplasms*/genetics , Central Nervous System Neoplasms*/blood, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Young Adult ; Adolescent ; Biomarkers, Tumor/cerebrospinal fluid ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; High-Throughput Nucleotide Sequencing ; Child

المؤلفون: Tateishi K; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University.; Laboratory of Biopharmaceutical and Regenerative Science, Graduate School of Medical Science, Yokohama City University.; Neurosurgical-Oncology Laboratory, Yokohama City University.

المصدر: Neurologia medico-chirurgica [Neurol Med Chir (Tokyo)] 2024 Sep 15; Vol. 64 (9), pp. 323-329. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Japan Neurosurgical Society Country of Publication: Japan NLM ID: 0400775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-8029 (Electronic) Linking ISSN: 04708105 NLM ISO Abbreviation: Neurol Med Chir (Tokyo) Subsets: MEDLINE

مواضيع طبية MeSH: Translational Research, Biomedical* , Central Nervous System Neoplasms*/therapy , Central Nervous System Neoplasms*/pathology , Central Nervous System Neoplasms*/diagnosis, Humans ; Animals

المؤلفون: Grommes C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Nandakumar S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Schaff LR; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Gavrilovic I; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Kaley TJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Nolan CP; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Stone J; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Thomas AA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Tang SS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wolfe J; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Bozza A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Wongchai V; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Hyde A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Barrett E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Lynch EA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Madzsar JT; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Lin A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Piotrowski AF; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Pentsova E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Francis JH; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Hatzoglou V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Schultz N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Reiner AS; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Panageas KS; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., DeAngelis LM; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurology, Weill Cornell Medical College, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4005-4015.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Adenine*/analogs & derivatives , Adenine*/therapeutic use , Piperidines*/therapeutic use , Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/secondary , Central Nervous System Neoplasms*/mortality , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Drug Resistance, Neoplasm ; Lymphoma/drug therapy ; Lymphoma/mortality ; Lymphoma/pathology ; Pyrazoles/therapeutic use ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; Pyrimidines/therapeutic use ; Pyrimidines/administration & dosage ; Pyrimidines/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/administration & dosage ; Treatment Outcome ; Agammaglobulinaemia Tyrosine Kinase/antagonists & inhibitors ; Agammaglobulinaemia Tyrosine Kinase/genetics ; Mutation

المؤلفون: Aboubakr O; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Houillier C; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Alentorn A; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Choquet S; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Dupont S; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Mokhtari K; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Leclercq D; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Nichelli L; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Kas A; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Rozenblum L; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Le Garff-Tavernier M; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Hoang-Xuan K; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Carpentier A; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Mathon B; From the Departments of Neurosurgery (O.A., A.C., B.M.), Neuro-Oncology (C.H., A.A., K.H.-X.), Hematology (S.C.), Epileptology (S.D.), Neuropathology (K.M.), Neuroradiology (D.L., L.N.), Nuclear Medicine (A.K., L.R.), and Biological Hematology (M.L.G.-T.), the Paris Brain Institute (ICM) (O.A., A.A., B.M.), LIB, INSERM U1146 (A.K., L.R.), INSERM U1127 (B.M.), CNRS UMR 7225 (B.M.), and GRC 23, Brain Machine Interface (A.C), La Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.

المصدر: Neurology [Neurology] 2024 Sep 10; Vol. 103 (5), pp. e209748. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Epilepsy*/epidemiology , Central Nervous System Neoplasms*/epidemiology , Central Nervous System Neoplasms*/complications, Humans ; Male ; Female ; Aged ; Retrospective Studies ; Middle Aged ; Risk Factors ; Prevalence ; Prognosis ; Lymphoma/epidemiology ; Lymphoma/complications ; Adult ; Aged, 80 and over

المؤلفون: Gupta M; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA.; Department of Neurosurgery, University of California San Diego, La Jolla, CA., Bradley JD; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Massaad E; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Burns EJ; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Georgantas NZ; Department of Pathology, Massachusetts General Hospital, Boston, MA., Maron GE; Department of Pathology, Massachusetts General Hospital, Boston, MA., Batten JM; Department of Pathology, Massachusetts General Hospital, Boston, MA., Gallagher A; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Thierauf J; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Department of Otorhinolaryngology, Head and Neck Surgery, Experimental Head and Neck Oncology, Heidelberg University Hospital, Heidelberg, Germany., Nayyar N; Cancer Center, Massachusetts General Hospital, Boston, MA., Gordon A; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Jones SS; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Pisapia M; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Sun Y; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Jones PS; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Barker FG 2nd; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Curry WT; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Gupta R; Department of Neuroradiology, Massachusetts General Hospital, Boston, MA., Romero JM; Department of Neuroradiology, Massachusetts General Hospital, Boston, MA., Wang N; Department of Medicine, Massachusetts General Hospital, Boston, MA., Brastianos PK; Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Neurology, Massachusetts General Hospital, Boston, MA.; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Martinez-Lage M; C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, MA., Tateishi K; Department of Neurosurgery, Yokohama City University, Yokohama, Japan., Forst DA; Cancer Center, Massachusetts General Hospital, Boston, MA., Nahed BV; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Batchelor TT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA., Ritterhouse LL; Department of Pathology, Massachusetts General Hospital, Boston, MA., Iser F; Department of Neurology and Neuro-Oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kessler T; Department of Neurology and Neuro-Oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Jordan JT; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Dietrich J; Cancer Center, Massachusetts General Hospital, Boston, MA.; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA., Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Lennerz JK; Department of Pathology, Massachusetts General Hospital, Boston, MA., Carter BS; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA., Shankar GM; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA.

المصدر: Blood [Blood] 2024 Sep 05; Vol. 144 (10), pp. 1093-1100.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Central Nervous System Neoplasms*/cerebrospinal fluid , Central Nervous System Neoplasms*/genetics , Central Nervous System Neoplasms*/diagnosis , Central Nervous System Neoplasms*/therapy , Lymphoma*/cerebrospinal fluid , Lymphoma*/genetics , Lymphoma*/diagnosis , Lymphoma*/therapy, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; DNA, Neoplasm/cerebrospinal fluid ; DNA, Neoplasm/genetics ; Aged, 80 and over ; Mutation ; Prospective Studies ; Young Adult

المؤلفون: Zeng Z; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China. zengzhiyong049@163.com.; Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. zengzhiyong049@163.com.; Fujian Lymphoma and Multiple Myeloma Working Group, Fuzhou, China. zengzhiyong049@163.com., Yang A; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Yang J; Parexel International, Durham, North Carolina, USA., Zhang S; Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Xing Z; Department of Imaging, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Wang X; Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Mei W; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Jiang C; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Lin J; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Wu X; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Xue Y; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Wu Z; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Yu L; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Wang D; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Chen J; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zheng S; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Lin Q; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Chen Q; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Dong J; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zheng X; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Wang J; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Huang J; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Chen Z; Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Chen P; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zheng M; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zhou X; Department of Imaging, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., He Y; Beijing tricision Biotherapeutics Inc., Beijing, China., Lin Y; Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China. lyx99070@163.com., Chen J; Department of Hematology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China. drjunminchen@fjmu.edu.cn.; Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. drjunminchen@fjmu.edu.cn.; Fujian Lymphoma and Multiple Myeloma Working Group, Fuzhou, China. drjunminchen@fjmu.edu.cn.

المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Sep 04; Vol. 9 (1), pp. 229. Date of Electronic Publication: 2024 Sep 04.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

مواضيع طبية MeSH: Methotrexate*/administration & dosage , Methotrexate*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Rituximab*/administration & dosage , Temozolomide*/administration & dosage , Temozolomide*/pharmacology , Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/genetics , Central Nervous System Neoplasms*/immunology , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/pharmacology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Lymphoma/drug therapy ; Lymphoma/genetics ; Lymphoma/immunology

المؤلفون: Li H; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Xiong M; National Genomics Data Center, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China.; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China., Li M; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Sun C; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China., Zheng D; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Yuan L; Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Chen Q; Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Lin S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Liu Z; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China., Ren X; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

المصدر: Cancer medicine [Cancer Med] 2024 Sep; Vol. 13 (17), pp. e70182.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Methotrexate*/therapeutic use , Methotrexate*/administration & dosage , Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/diagnostic imaging , Central Nervous System Neoplasms*/pathology , Magnetic Resonance Imaging*/methods, Humans ; Male ; Female ; Middle Aged ; Aged ; Lymphoma/drug therapy ; Lymphoma/diagnostic imaging ; Lymphoma/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Adult ; Prognosis ; Machine Learning ; Treatment Outcome ; Retrospective Studies ; Radiomics

المؤلفون: Tang Z; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China., Wu G; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.; Department of Pathology, Xiangya Hospital, Central South University, Changsha, China., Tan F; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China., Long Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China., Hong J; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China., Lyu Z; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China., Wei R; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China. weirui@csu.edu.cn.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. weirui@csu.edu.cn.

المصدر: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Sep; Vol. 200 (9), pp. 760-773. Date of Electronic Publication: 2024 Mar 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Urban & Vogel Country of Publication: Germany NLM ID: 8603469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-099X (Electronic) Linking ISSN: 01797158 NLM ISO Abbreviation: Strahlenther Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Central Nervous System Neoplasms*/mortality , Central Nervous System Neoplasms*/therapy, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Retrospective Studies ; Prognosis ; Lymphoma/mortality ; Lymphoma/therapy ; Aged, 80 and over ; Young Adult ; L-Lactate Dehydrogenase/blood ; Treatment Outcome ; Kaplan-Meier Estimate ; Induction Chemotherapy ; Progression-Free Survival ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Survival Rate ; Adolescent